GlassScriptPhysician profile
Rachel Catherine Angulo
NPI 1972954600
$694.38
in general payments reported to CMS, 2019-2025
21 companies · $200 in 2025
The $200 reported for 2025 was more than what 75% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.83 · 2023: $199 · 2024: $227 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $214.89 | 2021-2024 | Bexsero, Pediarix, Rotarix |
| Ironshore Pharmaceuticals INC. | $66.68 | 2024 | |
| Amgen INC. | $49.08 | 2023-2024 | Otezla, Repatha |
| Collegium Pharmaceutical, INC. | $29.95 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $28.97 | 2021-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Corium, LLC | $26.85 | 2025 | Azstarys |
| Baxter Healthcare | $25.52 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Sobi, INC | $24.52 | 2023 | |
| Pfizer INC. | $22.95 | 2025 | |
| Supernus Pharmaceuticals, INC. | $21.69 | 2023 | |
| Amarin Pharma, INC. | $20.75 | 2021 | |
| Lundbeck LLC | $19.66 | 2024 | Rexulti |
| Sanofi Pasteur INC. | $19.14 | 2025 | |
| Genentech USA, INC. | $18.99 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.45 | 2025 | Caplyta |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $17.01 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.38 | 2025 | Zoryve |
| Abbott Laboratories | $15.76 | 2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $15.51 | 2024 | |
| Lilly USA, LLC | $13.71 | 2023 | Trulicity, Mounjaro |
| Dynavax Technologies Corporation | $8.92 | 2025 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Angulo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.